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Summary
The differentiation of surface Ig- pre-B cells into surface Ig' B cells is a critical transition in
mammalian B cell ontogeny. Elucidation of the growth factor requirements and differentiative
potential ofhuman pre-Bcellshas been hampered by the absence of a reproducible culture system
that supports differentiation. Fluorescence-activated cell sorting and magnetic bead depletion
were used to purify fetal bone marrow CD10+/surface lc- cells, which contain 60-70%
cytoplasmic,u+ pre-B cells. CD10+/surface Ft
- cells cultured for 2 d were-observed to differentiate
into surface P,+ cells. Analysis by Southern blotting provided direct evidence that rearrangement
of K light chain genes occurs in culture, and flow cytometric analysis revealed the appearance
of surface Ig+ B cells expressing IA./K or /A/X . Unexpectedly, the tc/A ratio in differentiated cells
was the inverse of what is normally observed in adult peripheral blood. Differentiation occurs
in the absence of exogenous growth factors or cytokines, suggesting that a stimulus-independent
differentiativeinertia might characterize pre-Bcellsin vivo. Future use of this model will facilitate
our understanding of normal and abnormal human pre-B cell differentiation.
complex array of cells and molecules have been impli-
cated in regulating mammalian B cell ontogeny, and con-
siderable progress in elucidating this complexityhas been made
in the bone marrow (BM)t of mice (1). Although a similar
level of complexity almost certainly exists in human BM,
delineation of the cells and molecules that regulate human
B cell ontogeny is notably lacking (2). Although progress
has recently been made in characterizing the developmental
stages of human B cell precursors (BCP) by cell surface an-
tigen expression using multiparameter flow cytometry (3-6),
we know very little about the growth factor requirements
and differentiative potential ofthese cells. Several reports have
described the effect of various stimuli on the differentiation
of human BCP. Landreth and his colleagues observed that
urine preparations collected from a patient with cyclic neu-
tropenia could induce the appearance of pre-B (cytoplasmic
1.+/surface Ig) and surface Ig+ B cells in B cell-depleted
adult BM (7) . Hokland and his colleagues observed that
phorbol ester and/or human leukocyte-conditioned medium
induced the appearance of surface IgM in CD10+/CD20-
fetal BM lymphoid cells (8). Unfortunately, a thorough analysis
of the active components inducing differentiation was not
presented in either report. A very recent report indicated that
recombinant human 11,4 couldinduce the appearance ofboth
1 Abbreviations used in this paper. APC, allophycocyanin; BCP, B cell
precursors; BM, bone marrow; ME, mean fluorescence intensity.
pre-B and surface Ig+ B cells in CD24+ human fetal BM
lymphoid cells (9). Here we describe the establishment and
characterization of a reproducible short-term culture system
for analyzing the differentiation of normal human pre-B cells
to surface Ig+ B cells. Evidence is presented that active rear-
rangement of« light chain genes occurs in culture, with the
subsequent appearance of surface Ig+ B cells expressing J./tc
or,u/X . This culture system will now permit a rigorous anal-
ysis of this critical developmental transition in human B cell
ontogeny.
Materials and Methods
Cell Preparation.
￿
Fetal BM from normal 21-23-wk-old fetuses
was obtained in accordance with the guidelines of the University
of Minnesota Committee on the Use of Human Subjects in Re-
search. Femoral and humeral bones were flushed with RPMI-
1640/5% FCS. The low density leukocyteswere isolated from the
cell suspension by centrifugation over Histopaque (Sigma Chem-
ical Co., St. Louis, MO) and washed twice with RPMI-1640/5%
FCS. Monocytes were depleted by adherence to a plastic tissue cul-
ture flask for 1-2 h at 37°C in RPMI-1640/10% FCS. Cells were
stored overnight at 4°C in RPMI-1640/5% FCS before cell sorting.
Serologic Reagents.
￿
PE-conjugated anti-CD10 (l5-PE) and an
isotype-matched IgG2a-PE control were obtained from Coulter Im-
munology, Hialeah, FL. Murine mAbs recognizing human g heavy
chains (HB57), human tc light chains (HB61), CD11b/C3biR
(OKMI), glycophorin A types M and N, and an isotype-matched
IgG1 control were produced from hybridoma cells obtained from
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andanti-My9 (CD33) were kindly provided byJamesGriffin, Dana-
Farber Cancer Institute, Boston, MA. Anti-CD2 was produced
in ourlaboratory. Antibodies were purified from ascites on protein
A-Sepharose (Pharmacia Fine Chemicals, Piscataway, NJ)using the
method of Ey et al. (10). Purified HB57, HB61, and IgG1 were
conjugated to FITC or biotin using the methods of Goding (11).
A purified IgG1 murine mAb recognizing human A light chains
was obtained from Cappel Laboratories (No. 0201-0287; Malvern,
PA). F(ab')2 goat anti-human K conjugated to FITC, F(ab')2 goat
anti-human X conjugated to PE, and normal goat Ig conjugated
to FITC and PE were purchasedfrom Tago Diagnostics Inc., Burlin-
game, CA. The specificity of allreagents recognizing heavyor light
chains wasconfirmedusing humanB cell populations (B lympho-
blastoid cell lines andperipheral blood B cells). FITC-conjugated
goat anti-mouse Ig was purchased from Tago. FITC-conjugated
goat anti-mouse IgG1 waspurchasedfrom Southern Biotechnology
Associates Inc., Birmingham, AL. Streptavidin-allophycocyanin
(APC)waspurchasedfrom Becton Dickinson, Mountain View, CA.
Flow Cytometrp/Cell Sorting.
￿
Fetal BM cells were stained for
expression of CD10 (usingJ5-PE) and surfaceA(using HB57-FITC),
andFRCS-purifiedby two-colorcell sorting on aFACS IV (donors
1-3, Table 1) or a FACStar Plus (donors 4-8, Table 1), using our
previously described methods (12). Stained cells were kept on ice
before sorting, and aliquots of cells were sorted in 60-75-min in-
tervals. Cells sorted on the FACS IV were at 4°C, whereas cells
sorted on theFACStar Plus were at room temperature. Only cells
exhibiting low forward angle and low right anglelight scattering
properties (the lymphoid gate) were sorted. Three-color analysis
of surface W, a, and X was performed on a FACStar Plus. FITC
and PE were excited at 488 nm using a 300 mW setting on an
argon ionlaser.APCwasexcited at 635 nm using a40 mW setting
on a helium/neon laser. Single-color analysis of surface A., a, and
Awasperformedon aFACScan. Analyses were conductedon cells
fixed in 1% paraformaldehyde.
Magnetic Bead Depletion. Fetal BM CD10'/surface A lym-
phoid cells were also purified by magnetic bead depletion using
polymerparticles with magnetite-containing cores (DYNABEADS
M-450; Robbins Scientific, Mountain View, CA)conjugated to goat
anti-mouse IgG. Ficoll-Hypaque-isolated fetal BM cells were ad-
justed to 10-15 x 106 cells/ml in RPMI-1640/2% FCS. Cells were
then incubatedfor45 min at 4°C with saturating concentrations
of mAb to myeloid/monocytoid cells (My8, CD11b, CD33),
erythroid precursors (glycophorin A), T cells (CD2), and mature
B cells (surface 1.) . After one wash in RPMI-1640/2% FCS, DY
NABEADS were added to a final ratio of 5 beads to 1 cell. The
cell/DYNABEAD mixture was incubated for 60-90 min at 4°C
on a rotary shaker, and cells bound to the beads were separated
from free cells by 5 minexposure to aflat platemagnet. The highly
enriched (>95%) CD10'/surface u cells were washed once in
RPMI-1640/2% FCS and then cultured as described below.
Cell Cycle Analysis.
￿
Surface it' and surface Fi lymphoid cells
were analyzed for theircell cycle status usingthe UV excitable dye,
Hoechst 33342, essentially as described by Hollander et al. (13).
Briefly, fetal BM low density leukocytes were stained with HB57
(anti-A) or IgGl control myelomaprotein, andcounterstained with
FITC goat anti-mouse Ig. Thecells were fixed in 0.45% parafor-
maldehydein PBSovernight at 4°C, and then stainedwith 8 Ag/ml
Hoechst33342 (Sigma)in PBScontaining 0.5% Tween20 (Sigma)
overnight at 4°C. Cellswith lymphoid light scatter properties were
then examined for surface Ft expression and DNA binding of
Hoechst 33342 using a FACS 440. FITC was excited at 488 nm
using an argon ion laser, and detected using a 535/20 bandpass
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filter. Hoechst 33342was excitedby aUVenhanced argonionlaser
operating at 350-360 nm, and detected using a 435/25 bandpass
filter.
Cell Culture.
￿
After cell sorting or magnetic bead depletionthe
CD10+/surface,u purified cells were re-analyzed on a FACScan to
assess their purity. These cells were >95% CD10', but a minor
population containedlowlevelsurface Et in some ofthecell sorting
experiments (see Table 1). Post-sort viability was 393%. Cells were
suspended in RPMI-1640/10% FCSsupplemented with 1% wt/vol
L-glutamine, 100 U/ml penicillin and 100Ag/mlstreptomycin, to
a density of 0.4 x 106/ml. They were then aliquoted into 96-well
round-bottomed plates (200 Al/well), and cultured for2dat 37°C
in 5% C02. Wells were harvested, pooled, and thecells analyzed
for viability by trypan blue exclusion (range, 60-94% from 12
different fetalBM donors)before analysis of Ig gene rearrangement
and surface Ig expression. The source ofFCSused in theseexperi-
ments was HyClone Laboratories (Logan, UT) lot 1111795 (fetal
BM donors 1-5) and lot 1111807 (fetal BM donors 6-12).
Antigenic Modulation.
￿
Fetal BM cells were stained for expres-
sion ofCD10 and surfaceA usingJ5-PE and HB57-FITC, respec-
tively. Aftera30-min incubation at 4°Cthecells were washed twice,
dividedinto two aliquots, andheld at 4'C or room temperature.
At 15-min intervals an aliquot was removed from 4°C and room
temperature andfixedin 1% paraformaldehyde. Thecellswere then
analyzed on aFACScanby gating on lymphoid cellswith lowfor-
ward angle/low right angle light scatter properties.
Southern Blotting.
￿
Cellswere lysedovernight at 37°C with pro-
teinase K (0.5 mg/ml) in THE (10.0 mM Tris, 100 mM sodium
chloride, 1 mM EDTA)buffer containing 1% SDS. DNAwasiso-
lated by phenol/chloroform extraction and ethanol precipitation,
and suspended in TE. DNA was digested with 30 U of BamHI
(Bethesda Research Laboratories, Gaithersburg, MD) for8 h, and
digested DNA wastransferred by capillaryblotting to Gene Screen
Plus (NEN Research Products, Boston, MA). Themembraneswere
prehybridizedin 10% dextran sulfate, 1% SDS, 1 M sodium chlo-
ride and hybridized overnight at 65'C with a 32P-(d) CTRlabeled
2.4-kb genomic C, probe (14). The membranes were then sequen-
tially washed in 2x SSC, 0.5% SDS at room temperature for 10
min, 1x SSC, 0.5% SDS at 65°C for30 min, and(ifneeded)0.1x
SSC, 1% SDS at 65°C until thebackground was low. Bands were
visualized by autoradiography using X-Omat AR film (Eastman
Kodak, Rochester, NY)aftera3-4-dayexposure at -70°C. DNA
standardization was conducted with aTCR6 probe (C.), specific
forJSl, 5' untranslated to JSl, andCS (15). This probe was kindly
provided by Frank Griesinger andJohn Kersey, University of Min-
nesota.
Results
CD10ISurface,uExpression in Fetal BM.
￿
We initially sought
to establishareproducible experimental system for analyzing
differentiation of normal human pre-B cells using fetal BM
CD10+/surface A cells. This choice of markers was based
on ourobservation that CD10 is apan-B cell antigenin fetal
BM, being expressed on >95% of CD19+ cells and >95%
of surfacep+ cells (6). TheCD10+/surface fit- fetal BM lym-
phoid population contains cells at multiple stages of B (and
possibly T) lineage commitment, including 60-70% cyto-
plasmic A' pre-B cells, and is depleted of mature surface A+
B cells. A representative two-colorbivariatecontourplot with
the sorting gates used to separate CD10+/surface ft - (box A)
from CD10+/surface p.+ (box B) cells is shown in Fig. 1.W
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Consistent with data reported elsewhere (6), all surface p.+
cells co-express CD10, whereas no CD10-/surface p.+ cells
were detectable. Surface it was expressed on 24 ± 8% (range
18-39%, n = 7) offetal BM lymphoid cells. The small number
of CD10-/surface it- cells in the left, lower quadrant were
probably erythroid precursors, since theirlight scatteringprop-
erties are similar to lymphoid cells
)Surface sition ofSurface u in CD10+/Surface,u- Cells. We
initially attempted to confirm a recent report that suggested
that 11,4 could induce the differentiation of pre-B cells ->
B cells in FACS-purified CD24+ fetal BM lymphoid cells (9).
In experiments conducted with three individual fetal BM spec-
imens, recombinant human 114 (1-100 U/ml) did not in-
duce acquisition of cytoplasmic or surface /A in a dose-
dependent manner. Surprisingly, a consistent and dramatic
increase in surface ji was observed in CD10+/surface /A-
FACS-purified cells cultured in RPMI-1640/10% FCS alone.
Analysis of CD10+/surface j.- cells immediately following
FACS-purification is shown in a representative experiment
in Fig. 2. A small fraction (4%) of the post-sort cells ex-
pressed a very low level of surface t. (Fig. 2 B). After 2 d
in culture 26% of the cells were surface u+ (Fig. 2 D), with
a fourfold increase in surface tt fluorescence intensity com-
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Figure 1.
￿
Two-color bivariate contour
plot demonstrating the expression of cell
surface CD10 (y axis) and surface t (x
axis) on fetal BM lymphoid cells from
donor 7 in Table 1. Boxes define the
sorting gates used to purify CD10*/sur-
face u- (A) and CD10*/surface p* (B)
populations.
paredwith the post-sort analysis in Fig. 2B. Table 1 summa-
rizes experiments conducted with CD10+/surface p,- FACS-
purified cells isolated from eight different fetal BM donors.
The percent of residual surface /+ cells post-sort was 10 ±
6% (range 4-18%, n = 7). However, the fluorescence inten-
sity of the residual surface A was only 37 ± 23% (range
11-67%, n = 6), compared with surface A+ nonsorted cells.
Acquisition of surface p. on CD10+/surface A- lymphoid
cells was completely reproducible, with 38 ± 11% (range
23-50%, n = 8) of cells expressing surface p, after 2 d in
culture. It is noteworthy that this frequency of surface U+
lymphoid cells (38%) is greater than the frequency of surface
j,+ lymphoid cells (24%) in pre-sorted BM. Importantly,
surface 1t acquisition occurred usingtwo different lots ofFCS,
and detection was achieved using different polyclonal and
monoclonal anti-p, reagents.
Simple outgrowth or preferential survival of residual sur-
face A+ cells does not explain our results. As shown in Table
1, the FACS-purified CD10+/surface u cells were quiescent
in 2-d culture, with a viability of 75 ± 9% (range 60-91%,
n = 8) on day 2. Cell yield was 95 ± 36% (range 70-167%,
n = 6) compared with day 0. Furthermore, the FACS-purified
CD10+/surface p,+ cells shown in Fig. 1, box B were 70%W
m
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viable after 2 d in culture, compared with the FACS-purified
CD10+/surface i cells shown in Fig. 1 (box A) which were
72% viable after 2 d in culture. A direct analysis of the prolifer-
ative status of non-sorted surface /,+ and surface u fetal BM
lymphoid cells was conducted by two-color staining using
HB57-FITC to detect surface g, and Hoechst 33342 to ana-
Table 1.
￿
Appearance of Surface ,u on FACS-Purified
CD10+/Surface #- Cells
Surface W values represent percent of lymphoid cells (based on low
forward angle and right angle light scattering properties) expressing
surface p as determined by flow cytometry.
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Figure 2.
￿
Acquisition of surface
Fc after a 2-d culture of CD10*/
surface Et- FACS-purified fetal BM
lymphoid cells isolated from donor
6 in Table 1. (A) Negative control
staining (GI-FITC) of post-sort
cells, (B) residual surface IA de-
tected with HB57-FITC on post-
sort cells, (C) negative control
staining (GI-FITC) of cells cul-
tured for 2 d, (D) surface jA de-
tected with HB57-FITC on cells
cultured for 2 d. Vertical dashed
line defines background staining,
with >98% of the cells found in
channels to the left of the vertical
line in A and C.
lyze cell cycle. As shown in Fig. 3 (box A), surface 14+ cells
were >98% in Go/G1, with <2% detectable proliferating
cells in S and GZ +M. In contrast, a distinct population of
proliferating surface A cells (ti8% of total surface A cells)
were detectable (box C). These data are entirely consistent
with previous analyses of human BM, B lineage cells, which
concluded that surface /,+ B cells are quiescent (13, 17).
These collectivedata argue strongly against simple outgrowth
or preferential survival o£ surface tt+ cells as an explanation
for our results.
We also considered whether surface u might modulate
during the sorting procedure, thereby resulting in "contami-
nation" of the CD10+/surface Ft
- cells with modulated sur-
face 1,+ B cells. This was experimentally tested by sequen-
tially examining surface 14 on cells held at 4°C or room
temperature. Both temperatures were studied since donors
1-3 were sorted at 4°C, whereas donors 4-8 were sorted at
room temperature. As shown in Fig. 4, the percent of lym-
phoid cells expressing surface 1L and the level of surface p
expressed as mean fluorescence intensity (MFI) did not change
during a 75-min incubation at 4°C. Incubationat room tem-
perature resulted in a slight reduction in surface p,+ cells
from 8.9 to 7.6%, and a reduction in MFI from 60 to 44.
Similar results were obtained in a separate experiment. Thus,
in donors 4-8 the low level modulation of surface p, during
the final30-45 min of the sort would result in an insignificant
contribution (<3%) to the CD10+/surface u- sorted cells.
The dramatic increase in surface p,+ cells in Table 1 can there-
Donor
Surface
Post-sort
Et+
Day 2
Viable
Day 2
Yield
Day 2
1 ND 49 76 167
2 16 35 72 ND
3 18 50 60 ND
4 8 46 82 78
5 7 23 72 91
6 4 26 70 70
7 4 30 75 81
8 10 48 91 84DNA CONTENT
fore not be attributed to reexpression of surface it following
antigenic modulation.
Acquisition ofSurface K and A in CDI0+/Surface u - Cells.
The expression of K and X light chains on noncultured fetal
BM lymphoid cells is presented in Fig. 5 B. Gating on the
surface A.+ lymphoid cells by three-color analysis reveals no
significant population of u+/light chain- cells (Fig. 5 C).
Analysis of fresh fetal BM lymphoid cells from several donors
revealed that 11 ± 2% (range, 10-13%, n = 5) oflymphoid
cells expressed a and 12 ± 2% (range 10-14%, n = 3) ex-
pressed X. Acquisition of surface tr and X was examined using
CD10+/surface Ig cells isolated by magnetic bead depletion.
As shown in Table 2, the percent of residual light chain+
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cells after magnetic bead depletion was extremely low, and
this method was clearly superior to FACS for depleting sur-
face Ig+ cells. When these cells were cultured in RPMI-
1640/10% FCS a striking appearance of surface K+ (6.8 ±
3.6%, range 4-12%) and surface X+ (20.2 ± 9.4%, range
9-28%) was observed (Table 2). Sequential appearance ofsur-
face rc and X in CD10+/surface Ig cells isolated from donor
10 is shown in Fig. 6. Highly efficient removal of surface
Ig+ cells is demonstrated by the two-color rc/A profile at day
0. Since magnetic bead depletion was conducted at 4°C, an-
tigenic modulation cannot account for the absence ofdetect-
able surface Ig+ cells. A dramatic appearance of surface X+
and x+ cells is evident by day 1 (a >50-fold increase in sur-
80
Figure 3.
￿
Analysis of DNA content (de-
tected with Hoechst 33342) and surface
expression (detected with HB57 + FITC
goat anti-mouse Ig) on fetal BM lymphoid
cells. Horizontal dashed line distinguishes
surface A+ from surface p - cells, defined
by control staining with an IgGI myeloma
protein. (Box A) surface k+ cells in
GO/G1, (box B) surface tA
-
cells in Go/Gl,
box C-surface ju - cells in S and G2+M
phases of the cell cycle. The contour popu-
lation to the left of box B is an artifact,
and probably represents a small number of
cells that did not completely intercalate
Hoechst 33342.
Figure 4.
￿
Stability of surface p.
expression as a function of time
and temperature. Antigenic modu-
lation of surface ju was investi-
gated at 4°C or room temperature
(RT), as described in Materials
and Methods, and changes in sur-
face u expression are presented as
percent of surface u+ cells (left
profile) and mean fluorescence in-
tensity (MR, right profile).
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￿
Three-color analysis of cell surface u, x, X on Ficoll-Hypaque-isolated fetal BM lymphoid cells isolated from donor 7 in Table 1.
Analyses in A and B are gated on lymphoid cells exhibiting low forward angle andlow right angle light scatter. (A) Negative control staining
of lymphoid cells, (B) expression of surfa.;e K and X on lymphoid cells, (C) expression of surface K and X gated on only those lymphoid cells ex-
pressing surface p . .
face Ig+ cells compared with day 0), and continues to in-
crease up to 4 d in culture. Two points are worth emphasizing
regarding these experiments . First is the significant reversal
of the K/A ratio in differentiated cells from all four donors
studied . Second is the fact that differentiation occurred in
theabsenceofcell-bound anti-CD10mAb, since the purification
of CD10+/surface Ig cells by magnetic bead depletion was
accomplished by negative selection .
K Gene Rearrangement.
￿
We next determined whether ac-
quisition of cell surface tc was due to rearrangement of Klight
chain genes in vitro, or transcriptional activation of prior func-
tional rearrangements in vivo. Fig. 7 is a Southern blot ob-
tained by hybridizing BamHI digests with a CK genomic
probe. Fig. 7 (top) shows the 12-kb germline band in the
CCRF-CEM T leukemic cell line (lane 1), and a single 7-kb
rearrangement in the BET-2 B lymphoblastoid cell line (lane
4) . Lanes 2 and 3 represent CD10+/surface p.' cells post
magnetic bead depletion and after 2 d in culture, respectively.
Table 2.
￿
Appearance ofSurfaceKand 11 on Magnetic Beadpurified
CDIO+/Surface u- Cells
Surface K+
￿
Surface X+
Viable Yield
Surface K and X values represent percent of lymphoid cells (based on
low forward angle and right angle light scattering properties) ex-
pressing surface K or A as determined by flow cytometry.
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A decrease in the intensity of the 12-kb germline band and
the presence of a new 20-kb rearrangement in 2 d cultured
cells (lane 3), compared with post-magnetic bead depleted
cells (lane 2), is evident . Similar results were obtained using
cells from two other fetal BM donors . The 20-kb rearrange-
ment was not present inCCRF-CEM (lane 1) orBET-2 (lane
4), nor has it been observed using these cell lines as controls
in separate experiments. Furthermore, analysis of fibroblasts
from one fetalBM donor revealed no 20-kb band (data not
shown), confirming that this is a specific rearrangement and
not a RFLP. Prolonged exposure of Southern blots revealed
a faint 20-kb rearrangement in noncultured C13101/surface
cells (data not shown) . Thus, this could constitute a non-
transcribed functional rearrangement that increases in fre-
quency in cultured CD10+/surface g cells.
When the blot at the top of Fig. 7was stripped and rehy-
bridized with the TCR6 probe Cx , identical amounts of
DNA were demonstrated in lanes 2 and 3 (Fig . 7, bottom).
The absence of detectable rearrangements in lanes 2 and 3
is also consistent with data to be reported elsewhere, indi-
cating thatTCRS rearrangements cannot be detected in fetal
BM B lineage cells by Southern blotting (17a) .
Discussion
The differentiation of surface Ig- pre-B cells into surface
Ig+ B cells is a critical transition in mammalian B cell on-
togeny. Much of our current knowledge regarding this tran-
sition is derived from murine studies using normal BM lym-
phoid cells, leukemic cell lines, Abelson transformants, and
Whitlock--Witte cultures (reviewed in reference 18) . In vitro
studies conducted with normal (7-9) and fresh leukemic (19)
human pre-B cells have described at least partial acquisition
of surface Ig in vitro, although the culture conditions and
source ofcells varied between laboratories. In the current study
we describe a cytokine/growth factor-independent, reproduc-
Donor
Post-
deplete Day 2
Post-
deplete Day 2 Day 2 Day 2
9 <1 6 <1 28 94 74
10 0 4 <1 9 74 70
11 <1 5 2 28 60 50
12 1 12 3 16 84 87Figure 6.
￿
Two-color bivariate contour plot examining the daily
levels of surface K' (x-axis) and X' (y-axis) using magnetic bead-
purified CD10'/surface p- cells cultured up to 4 d. The contour
plots in the left column are the daily control stainings used to set the
background gates for K/A detection . The intensity of the contour
profiles on day 4 are decreased because only half as many cells were
available for analysis . Fetal BM cells were from donor 10 in Table 1 .
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Figure 7.
￿
Southern blot analysis of is rearrangements. DNA was
digested with BamHI and hybridized with a [32p]dCTP-labeled
genomic C,, probe (top) . The blot was then stripped and rehybridized
(bottom) with a P2P]dCTP-labeled cDNA TCR6 probe, designated
C., specific for J61, 5' untranslated to J61, and C6 . (Lane 1) CCRF-
CEM T leukemic cell line, (lane 2) CD10*/surface q - cells isolated
by magnetic bead depletion, (lane 3) same cells as lane 2 but cultured
for 2 d in RPMI-1640/10% FCS, (lane 4) BET-2 B lymphoblastoid
cell line. The cells in lane 2 were <1% surface u, and X' . The cells
in lane 3 were 9% rz' and 18% X' . Horizontal lines identify germ-
line fragments, horizontal arrows identify rearranged fragments.
ible culture system that supports human pre-B to B cell
differentiation of normal cells . The salient characteristics of
our culture system include direct evidence that : (a) K light
chain gene rearrangement occurs in culture, and (b) cells ac-
quire cell surface / .6/K or cell surface u/X Ig receptors .
CD10+/surface A .- fetal BM lymphoid cells were selected
as the starting population in our experiments since we have
recently shown that CD10 is a pan-B cell antigen in fetal
BM, being expressed on >95% of CD19' and>95% of sur-
face A.+ cells (6) . The CD10+/surface I,- population contains
cytoplasmic u BCP and cytoplasmic g' pre-B cells (ratio
of ti1 :2), but accessory cells (e.g., T cells, macrophages, or
stromal cells) that may affect pre-B cell differentiation are
absent. We (20) are unaware of reports implicating CD10,
nowknown to be theenzyme neutral endopeptidase (21, 22),
in regulating proliferation or differentiation oflymphoid cells .
Anti-CD10 does not deliver a direct differentiatioe signal to
pre-B cells in our culture system since CD10+/surface A-cells differentiate in the absence of cell-bound anti-CD10 (Fig.
6, Table 2) .
Data in Figs. 2 and 6 and Tables 1 and 2 provide direct
evidence that CD10+/surface p,- cells differentiate in vitro
into surface Ig+ cells expressing A./u or p ./X . Additional,
corroborative evidence shows that K light chain gene rear-
rangements occur, based on the decrease in the intensity of
the germline K band in CD10+/surface p,- cells cultured for
2 d (Fig. 7, top, lane 3). Current models of light chain gene
rearrangement in both mouse (23, 24) and man (25, 26)
strongly argue for a K - A hierarchy. Thus, the decrease in
intensity of the germline u band (Fig. 7) probably reflects
functional Krearrangements, and most likely is deletions fol-
lowed by functional (and possibly nonfunctional) A rearrange-
ments. Future studies that analyze V is and V X usage in
CD10+/surface p,- cultured cells will shed more light on this
issue.
An unexpected observation was the striking preponder-
ance of surface X+ over surface K+ cells in our pre-B cell
differentiation culture system. This was a consistent finding
in all four donors (Table 2), and was observed sequentially
up to 4 d in culture (Fig. 6). Reagent specificity does not
explain this phenomenon since identical results were obtained
using polyclonal and monoclonal anti-light chain reagents.
Furthermore, the reagents used in this study detected K+ and
X+ cells at the expected 2:1 ratio in peripheral blood. At
least two other explanations can be offered. First, the high
percent of A+ cells may include bona fide X and the recently
described w light-chain protein (27, 28). Alternatively, a mech-
anism may exist in vivo for regulating the a/A ratio that is
absent from our culture system.
Several prior studies have examined in vitro differentiation
of human pre-B cells from normal BM (7-9, 29), and BM
from patients following chemotherapy for treatment of
leukemia (29, 30). It is difficult to directly compare our data
with previous reports, since no two studies used precisely
the same cell isolation procedures, culture conditions, and
methods of serologic analysis. Serum source alone may not
explain our observations, since pre-B cell differentiation in
our culture system was reproducible in two separate lots of
FCS. Hokland et al. reported some evidence of pre-B cell
differentiation using fetal BM cells enriched for a CD10+/
CD20- phenotype and cultured in phorbol ester plus leu-
kocyte-conditioned medium (8). Cells cultured in medium
alone were not investigated. Hofman et al. utilized FACS-
purified CD24+ cells cultured in the presence or absence of
a fetal BM-derived adherent cell feeder layerto observe pre-B
to B cell differentiation in the presence ofIL4 (9) . No differen-
tiation occurred in the absence of IL4. Our results differ sub-
stantially with Hofman et al.; we observed no obligatory or
potentiating effect of IL4. A major difference between our
studies and those of Hofman et al. was the cell isolation
strategy. FACS-purified CD24+ fetal BM lymphoid cells (9)
would encompass cells at all stages of B lineage development
except plasma cells, including surface tt+ B cells (31, 32). In
contrast, FACS-purified CD10+/surface ,tc cells used in our
study were largely depleted of surface A+ cells, and magnetic
bead-purified CD10+/surface A cells were completely de-
pleted of surface p.+ cells. We would emphasize that the data
reported herein are the first to examine rearrangement of
light chain genes and acquisition of surface )A/K, surface
p,/X in normal, differentiating human pre-B cells.
The growth factor/cytokine-independent nature ofnormal
pre-B cell differentiation described in this study suggests that
a stimulus-independent differentiative inertia might charac-
terize these cells in vivo. This "spontaneous" differentiation
bears a striking resemblance to that observed in a leukemic
cell line, designated BLIN-1, recently established in this lab-
oratory (33) . BLIN-1 was established from a patient with
pre-B acute lymphoblastic leukemia. The hallmark charac-
teristic of BLIN-1 is its propensity to undergo spontaneous
pre-B -> B cell differentiation, characterized by functional
rearrangement and expression of is light chain genes (33).
Differentiation cannot be enhanced by several cytokines tested
to date, but is enhanced by culturing BLIN-1 cells in low
serum, or serum-free medium (33) . The recombinase en-
zyme(s) and transcriptional factors that mediate rearrange-
ment and expression of rc light chain genes may be under
similar control in normal pre-B cells and the BLIN-1 pre-B
ALL cell line. Although not directly comparableto our studies
because of differences in experimental design, data derived
from murine studies also support the occurrence of "sponta-
neous" pre-B cell differentiation in vitro. Kincade et al. ob-
served the formation of surface p+ clones in semisolid agar
from normal BM depleted of surface p.+ cells (34). Surface
A+ clones were not formed unless the BM cells were initially
cultured in liquid suspension for 24 h. One notable differ-
ence between our studies and those of Kincade et al. is the
accessory cell or soluble mediator dependency of murine pre-B
cell differentiation.
In conclusion, we have established and characterized an
experimental system for studying the differentiation of normal
human pre-B cells. The existence of extensive K light chain
gene rearrangements, and the subsequent appearance of sur-
face Ig+ B cells expressing 1A/rc or p,A, suggests this cul-
ture system is a legitimate model that may recapitulate pre-B
cell differentiation in vivo. Future use of this model should
hasten elucidation of soluble mediators that may regulate pre-B
cell differentiation and analysis of light chain V gene usage,
which in turn could provide insights into the etiology of
immunodeficiencies or lymphoproliferative disorders involving
pre-B cells.
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